Simplex Trading’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $115 | Buy |
25,400
+2,900
| +13% | +$298K | ﹤0.01% | 8869 |
|
|
2025
Q4 | $2.29M | Sell |
22,500
-42,000
| -65% | -$3.37M | ﹤0.01% | 1873 |
|
|
2025
Q3 | $3.53M | Buy |
64,500
+5,400
| +9% | +$270K | ﹤0.01% | 1782 |
|
|
2025
Q2 | $3.14M | Buy |
59,100
+24,700
| +72% | +$1.25M | ﹤0.01% | 1718 |
|
|
2025
Q1 | $1.49M | Sell |
34,400
-52,700
| -61% | -$2.67M | ﹤0.01% | 2325 |
|
|
2024
Q4 | $4.89M | Sell |
87,100
-134,600
| -61% | -$8.38M | ﹤0.01% | 1493 |
|
|
2024
Q3 | $15.1M | Buy |
221,700
+136,700
| +161% | +$7.71M | 0.01% | 789 |
|
|
2024
Q2 | $3.59M | Sell |
85,000
-195,200
| -70% | -$10.7M | ﹤0.01% | 1674 |
|
|
2024
Q1 | $19.4M | Buy |
280,200
+140,100
| +100% | +$8.86M | 0.01% | 714 |
|
|
2023
Q4 | $10.4M | Buy |
140,100
+98,400
| +236% | +$6.45M | 0.01% | 1063 |
|
|
2023
Q3 | $2.84M | Sell |
41,700
-56,400
| -57% | -$4.79M | ﹤0.01% | 1785 |
|
|
2023
Q2 | $9.21M | Buy |
98,100
+59,100
| +152% | +$4.61M | 0.01% | 943 |
|
|
2023
Q1 | $2.64M | Sell |
39,000
-94,100
| -71% | -$6.05M | ﹤0.01% | 1712 |
|
|
2022
Q4 | $6.59M | Buy |
133,100
+74,600
| +128% | +$3.05M | 0.01% | 1071 |
|
|
2022
Q3 | $1.9M | Buy |
58,500
+47,400
| +427% | +$1.95M | ﹤0.01% | 2002 |
|
|
2022
Q2 | $437K | Sell |
11,100
-39,400
| -78% | -$2.11M | ﹤0.01% | 3602 |
|
|
2022
Q1 | $3.53M | Sell |
50,500
-11,900
| -19% | -$870K | ﹤0.01% | 1551 |
|
|
2021
Q4 | $4.86M | Buy |
62,400
+12,700
| +26% | +$1.12M | ﹤0.01% | 1225 |
|
|
2021
Q3 | $6.17M | Hold |
49,700
| – | – | 0.01% | 1032 |
|
|
2021
Q2 | $6.18M | Buy |
49,700
+49,383
| +15,578% | +$5.89M | 0.01% | 1008 |
|
|
2021
Q1 | $4.18M | Buy |
+317
| New | +$43.4K | 0.01% | 959 |
|
|
2020
Q4 | – | Sell |
-1,056
| Closed | -$10.8M | – | 8537 |
|
|
2020
Q3 | $10.8M | Sell |
1,056
-143
| -12% | -$12.3K | 0.01% | 489 |
|
|
2020
Q2 | $10.4M | Buy |
1,199
+203
| +20% | +$16.2K | 0.02% | 511 |
|
|
2020
Q1 | $5.78M | Buy |
+996
| New | +$80.9K | 0.01% | 628 |
|
|
2019
Q4 | – | Sell |
-1,178
| Closed | -$10.6M | – | 7455 |
|
|
2019
Q3 | $10.6M | Buy |
1,178
+86
| +8% | +$9.8K | 0.03% | 400 |
|
|
2019
Q2 | $12.9M | Buy |
1,092
+567
| +108% | +$57.1K | 0.04% | 327 |
|
|
2019
Q1 | $4.55M | Sell |
525
-556
| -51% | -$47.3K | 0.01% | 744 |
|
|
2018
Q4 | $6.82M | Sell |
1,081
-637
| -37% | -$43.7K | 0.02% | 459 |
|
|
2018
Q3 | $13.6M | Buy |
1,718
+1,210
| +238% | +$78.9K | 0.04% | 280 |
|
|
2018
Q2 | $3.04M | Sell |
508
-268
| -35% | -$14.4K | 0.01% | 840 |
|
|
2018
Q1 | $506K | Buy |
776
+159
| +26% | +$7.76K | 0.02% | 708 |
|
|
2017
Q4 | $158K | Buy |
617
+10
| +2% | +$534 | 0.01% | 1454 |
|
|
2017
Q3 | $39K | Buy |
607
+1
| +0.2% | +$40 | ﹤0.01% | 2531 |
|
|
2017
Q2 | $58K | Buy |
606
+179
| +42% | +$5.53K | ﹤0.01% | 2248 |
|
|
2017
Q1 | $114K | Sell |
427
-469
| -52% | -$9.29K | ﹤0.01% | 1639 |
|
|
2016
Q4 | $331K | Buy |
896
+179
| +25% | +$2.89K | 0.02% | 757 |
|
|
2016
Q3 | $164K | Sell |
717
-720
| -50% | -$12.7K | 0.01% | 1167 |
|
|
2016
Q2 | $202K | Buy |
1,437
+1,022
| +246% | +$7.7K | 0.01% | 986 |
|
|
2016
Q1 | $268K | Buy |
415
+313
| +307% | +$2K | 0.02% | 710 |
|
|
2015
Q4 | $108K | Buy |
102
+34
| +50% | +$316 | 0.01% | 1286 |
|
|
2015
Q3 | $85K | Sell |
68
-22
| -24% | -$505 | 0.01% | 1537 |
|
|
2015
Q2 | $43K | Buy |
90
+33
| +58% | +$829 | ﹤0.01% | 1800 |
|
|
2015
Q1 | $54K | Sell |
57
-126
| -69% | -$3.2K | 0.01% | 1499 |
|
|
2014
Q4 | $55K | Buy |
+183
| New | +$4.45K | 0.01% | 1317 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
Simplex Trading's EXAS Position: Q1 2026 in Review
Simplex Trading sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 22,521 shares — an estimated $2.32M sold.
Simplex Trading first reported a position in EXAS in Q1 2016 and held it in 24 quarters. The position peaked at $8.14M in Q1 2024. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Simplex Trading reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 22,521 Exact Sciences shares in Q1 2026, an estimated $2.32M.
- Simplex Trading first reported a position in Exact Sciences in Q1 2016 and held it in 24 quarters.
- Simplex Trading's Exact Sciences position peaked at $8.14M in Q1 2024.
- 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.